CHINA PHARMA HOLDINGS, INC. Quarterly Depreciation in USD from Q2 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
China Pharma Holdings, Inc. quarterly/annual Depreciation history and growth rate from Q2 2016 to Q3 2024.
  • China Pharma Holdings, Inc. Depreciation for the quarter ending September 30, 2024 was $592K, a 6.1% decline year-over-year.
  • China Pharma Holdings, Inc. annual Depreciation for 2023 was $2.53M, a 5.03% decline from 2022.
  • China Pharma Holdings, Inc. annual Depreciation for 2022 was $2.66M, a 12.6% decline from 2021.
  • China Pharma Holdings, Inc. annual Depreciation for 2021 was $3.05M, a 15.4% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $592K -$38.5K -6.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $637K -$4.26K -0.66% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q4 2023 $2.53M $617K -$43.4K -6.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $2.57M $631K -$24.8K -3.79% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $2.6M $641K -$33K -4.89% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $2.63M $641K -$33K -4.89% Jan 1, 2023 Mar 31, 2023 10-Q 2023-08-14
Q4 2022 $2.66M $661K -$40.4K -5.76% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $2.7M $655K -$312K -32.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $3.02M $674K -$17K -2.46% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.03M $674K -$16.8K -2.43% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-14
Q4 2021 $3.05M $701K +$9.27K +1.34% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $3.04M $967K +$303K +45.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.74M $691K +$50.5K +7.88% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.69M $691K +$43.6K +6.74% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.64M $692K +$33.4K +5.08% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.61M $664K -$13K -1.92% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $2.62M $640K -$122K -16% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $2.75M $647K -$126K -16.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.87M $658K +$105K +18.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 $2.77M $677K -$265K -28.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $3.03M $762K -$57K -6.96% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $3.09M $773K -$55.1K -6.65% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 $3.14M $554K -$257K -31.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $3.4M $943K +$163K +20.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $3.24M $820K +$49.1K +6.37% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $3.19M $828K +$63.3K +8.28% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $3.13M $811K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $780K -$9.29K -1.18% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $770K -$152K -16.4% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $765K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 $789K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $922K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.